{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:33:21Z","timestamp":1764783201605},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.juro.2010.03.149","type":"journal-article","created":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T08:41:40Z","timestamp":1276850500000},"page":"494-500","source":"Crossref","is-referenced-by-count":47,"title":["The Association Between Statin Use and the Diagnosis of Prostate Cancer in a Population Based Cohort"],"prefix":"10.1097","volume":"184","author":[{"given":"Rodney H.","family":"Breau","sequence":"first","affiliation":[{"name":"Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra J.","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela E.","family":"McGree","sequence":"additional","affiliation":[{"name":"Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Jacobsen","sequence":"additional","affiliation":[{"name":"Southern California Permanente Medical Group, Pasadena, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Nehra","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Lieber","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"St. Sauver","sequence":"additional","affiliation":[{"name":"Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2010.03.149_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer Statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2010.03.149_bib2","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.urology.2009.03.003","article-title":"Current prostate cancer treatments: effect on quality of life","volume":"73","author":"Gomella","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.03.149_bib3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrc1751","article-title":"Statins and cancer prevention","volume":"5","author":"Demierre","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.juro.2010.03.149_bib4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1158\/1055-9965.EPI-07-0531","article-title":"Statin induces apoptosis and cell growth arrest in prostate cancer cells","volume":"17","author":"Hoque","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.juro.2010.03.149_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jcb.10724","article-title":"Cholesterol and prostate cancer","volume":"91","author":"Freeman","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.juro.2010.03.149_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/aje\/kwn141","article-title":"Statin use and risk of prostate cancer: results from a population-based epidemiologic study","volume":"168","author":"Agalliu","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.juro.2010.03.149_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00001648-200205000-00005","article-title":"Statin use and the risk of breast and prostate cancer","volume":"13","author":"Coogan","year":"2002","journal-title":"Epidemiology"},{"key":"10.1016\/j.juro.2010.03.149_bib8","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1158\/1055-9965.EPI-07-0197","article-title":"Statin use and risk of prostate cancer in the California Men's Health Study cohort","volume":"16","author":"Flick","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.juro.2010.03.149_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.20758","article-title":"Cancer risk among statin users: a population-based cohort study","volume":"114","author":"Friis","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2010.03.149_bib10","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2004.02.027","article-title":"The risk of cancer in users of statins","volume":"22","author":"Graaf","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2010.03.149_bib11","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1158\/1055-9965.EPI-07-0448","article-title":"Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort","volume":"16","author":"Jacobs","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.juro.2010.03.149_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.bjc.6601566","article-title":"Statin use and cancer risk in the General Practice Research Database","volume":"90","author":"Kaye","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2010.03.149_bib13","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1055-9965.EPI-07-0599","article-title":"Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study","volume":"16","author":"Murtola","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.juro.2010.03.149_bib14","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/jnci\/djj499","article-title":"Statin drugs and risk of advanced prostate cancer","volume":"98","author":"Platz","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2010.03.149_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/aje\/kwi203","article-title":"Statins and prostate cancer risk: a case-control study","volume":"162","author":"Shannon","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.juro.2010.03.149_bib16","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/archinte.160.15.2363","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study","volume":"160","author":"Blais","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.juro.2010.03.149_bib17","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/jnci\/djn362","article-title":"The influence of statin medications on prostate-specific antigen levels","volume":"100","author":"Hamilton","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2010.03.149_bib18","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/01.ju.0000158044.94188.88","article-title":"The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report","volume":"173","author":"Cyrus-David","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.03.149_bib19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archfami.2.7.729","article-title":"A population-based study of health care-seeking behavior for treatment of urinary symptoms","volume":"2","author":"Jacobsen","year":"1993","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.juro.2010.03.149_bib20","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.270.7.860","article-title":"Serum prostate-specific antigen in a community-based population of healthy men","volume":"270","author":"Oesterling","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2010.03.149_bib21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/ijc.23550","article-title":"Statin use and the risk of prostate cancer: a metaanalysis of 6 randomized clinical trials and 13 observational studies","volume":"123","author":"Bonovas","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2010.03.149_bib22","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2010.03.149_bib23","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(02)08351-4","article-title":"Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2010.03.149_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1741-7015-3-6","article-title":"The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]","volume":"3","year":"2005","journal-title":"BMC Med"},{"key":"10.1016\/j.juro.2010.03.149_bib25","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2010.03.149_bib26","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa065994","article-title":"Long-term follow-up of the West of Scotland Coronary Prevention Study","volume":"357","author":"Ford","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2010.03.149_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(04)16936-5","article-title":"Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)","volume":"364","author":"Strandberg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2010.03.149_bib28","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1158\/1055-9965.EPI-07-0777","article-title":"Epidemiologic musing on statin drugs in the prevention of advanced prostate cancer","volume":"16","author":"Platz","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.juro.2010.03.149_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2288-6-58","article-title":"Dropout in a longitudinal, cohort study of urologic disease in community men","volume":"6","author":"Gades","year":"2006","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.juro.2010.03.149_bib30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/14740330802396984","article-title":"Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality","volume":"7","author":"Liberopoulos","year":"2008","journal-title":"Expert Opin Drug Saf"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710032775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710032775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2010.03.149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:46:21Z","timestamp":1651196781000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2010.03.149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1016\/j.juro.2010.03.149"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2010.03.149","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}